Quick Answer
CHS INC reported Cash and Equivalents of $327.83 million for fiscal year 2025.
CHS INC Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $327.83M | -58.8% |
| 2024 | $794.87M | -55.0% |
| 2023 | $1.77B | +122.3% |
| 2022 | $793.96M | +92.2% |
| 2021 | $413.16M | +193.3% |
| 2020 | $140.87M | -33.3% |
| 2019 | $211.18M | -53.1% |
| 2018 | $450.62M | -15.6% |
| 2018 | $533.89M | +143.5% |
| 2018 | $219.27M | -12.2% |
| 2017 | $249.77M | +37.7% |
| 2017 | $181.38M | -32.0% |
| 2017 | $266.75M | -3.4% |
| 2017 | $276.14M | -46.6% |
| 2016 | $516.65M | +78.0% |
| 2016 | $290.27M | -70.0% |
| 2015 | $967.72M | -54.6% |
| 2014 | $2.13B | +18.0% |
| 2013 | $1.81B | +475.9% |
| 2012 | $314.03M | -66.5% |
| 2011 | $937.68M | +137.6% |
| 2010 | $394.66M | -48.9% |
| 2009 | $772.60M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | $374.69M | -16.8% | +14.3% |
| August 31, 2025 | $327.83M | -58.8% | +1.2% |
| May 31, 2025 | $323.86M | +4.4% | -25.3% |
| February 28, 2025 | $433.30M | -31.6% | -3.8% |
| November 30, 2024 | $450.49M | -66.6% | -43.3% |
| August 31, 2024 | $794.87M | -55.0% | +156.3% |
| May 31, 2024 | $310.13M | -68.9% | -51.0% |
| February 29, 2024 | $633.29M | +37.0% | -53.1% |
- CHS INC showed a decrease of -58.8% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2009–2025 period, CHS INC’s cash and equivalents has declined by 57.6% (from $772.60 million to $327.83 million).
- The most recent figure is from CHS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on November 5, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: